Endonovo Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3.30
1.00
41.50
55.50
90.20
379.20
Other Current Assets
-
2.00
336.20
247.30
21.00
-
Total Current Assets
3.30
3.00
377.70
302.90
111.20
382.50
Net Property, Plant & Equipment
58.30
42.60
31.70
15.80
1.10
6.70
Total Investments and Advances
12.00
-
-
-
-
-
Long-Term Note Receivable
-
1.60
1.60
1.60
1.60
1.60
Intangible Assets
-
-
-
-
4,500.00
3,853.10
Total Assets
73.60
47.20
410.90
320.20
4,613.80
4,243.90
ST Debt & Current Portion LT Debt
714.50
1,387.60
1,518.80
2,060.50
4,735.40
Accounts Payable
3,293.90
3,167.30
3,990.20
-
-
Other Current Liabilities
-
0.00
3,977.10
6,660.80
8,674.00
Total Current Liabilities
4,008.40
4,554.90
9,486.20
8,721.30
13,409.30
Long-Term Debt
42.40
28.60
44.30
4.20
598.20
Other Liabilities
155.00
155.00
155.00
155.00
155.00
Total Liabilities
4,205.80
4,738.60
9,685.40
8,880.50
14,162.50
Common Equity (Total)
4,132.20
4,691.40
9,274.50
8,560.30
9,548.70
Total Shareholders' Equity
4,132.20
4,691.40
9,274.50
8,560.30
9,548.70
Total Equity
4,132.20
4,691.40
9,274.50
8,560.30
9,548.70
Liabilities & Shareholders' Equity
73.60
47.20
410.90
320.20
4,613.80
Preferred Stock (Carrying Value)
-
-
-
-
0.00
About Endonovo Therapeutics
View Profile
